Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
about
The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis CDirect effects of hepatitis C virus on the lymphoid cellsHepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine modelHepatitis C virus-related extra-hepatic disease--aetiopathogenesis and management.Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopenia.Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alphaXerostomia due to systemic disease: a review of 20 conditions and mechanisms.Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosisHost genetic determinants in hepatitis C virus infection.Management of chronic hepatitis C virus infection: a new era of disease control.Treating viral hepatitis C: efficacy, side effects, and complications.Present and future therapy for hepatitis C virus.Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease.Adaptive immune response during hepatitis C virus infection.Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.Hepatitis C virus cryoglobulinemia and non-hodgkin lymphomaOral conditions associated with hepatitis C virus infection.The first report of the thyroid function of haemophilic patients with HIV/HCV co-infection in Japan.Hepatitis C virus infection and its rheumatologic implications.Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients.Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions.Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life.Lichen sclerosus-lichen planus overlap in a patient with hepatitis C virus infection.Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.Hepatitis C-associated autoimmunity in patients coinfected with HIV.Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients.Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist?Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.Hepatitis status and mortality in hemodialysis population.
P2860
Q24801439-B7E9C7F5-8460-42B8-8468-121E1476BDDBQ26992142-32ED96CD-05B9-4A84-B7AD-DC5ECC6085CDQ27472895-FABA1F6F-E368-45F0-8D81-2479ECE2BCAFQ33361560-2D5F4D81-D317-4B94-9D99-D91CF8D59BB5Q33372989-E0D0E998-72C9-4D6E-AD27-CFAA8F54E422Q33909777-0359798A-3F4C-4BC8-BDDE-86BF577D665EQ34162332-EC7CE30B-DBC6-4F07-8C2B-297298846DC8Q34261832-22657404-3164-4D20-9A25-FCDE12FDCDC7Q35753723-9D589C92-E612-417D-801A-BECFA94711A4Q35823410-02E1D5CA-1859-473E-ABC9-26DA0874D537Q36564615-0C9DD0AC-6EC0-449A-AB9C-6AB473DC41B8Q36670887-53B00A08-D88E-4F37-87C4-7928F85C29D2Q37672213-B1DF42BF-D8AB-4789-8FD9-C740CAE7AFD7Q37682489-30E1C48F-9B11-4F9D-BF21-7E3A8098FECDQ37683158-502E64B1-AB4E-4A85-973C-B423E425FC62Q37851006-BF6115B5-E786-44E7-A473-01979B6E63ADQ38003148-6BFA9B57-E75E-4051-80DC-FC86E66759ACQ38160291-225A307D-CD07-42BE-AA80-5C07E0196FB4Q39775992-F5AE74F5-355D-4330-A1BD-5DE2945D2B48Q41560603-1C71F3BF-BA29-4254-A502-F8B653915C8DQ42982075-D934B90C-57F6-4A9D-A10F-66FC58E07E17Q43034069-CD89B8BE-5C99-4F11-8194-291881193D7AQ43652474-91F9F506-0F48-4415-AFA8-93BCF046F21DQ43788274-179A9F10-0B16-4724-9708-9FB9F2EB1B41Q45415714-81A71961-BA7B-4FBF-AD49-A8291236B532Q45696723-A6A64CFA-6B37-4EE4-9B73-1ED737751233Q45738814-C7629C16-014D-4E31-ABC1-925EE6CEB70EQ45739101-84841FE5-0315-4B92-B375-8310754F2C76Q46846712-B8A0F9C2-DB0E-40B2-AAE5-ED667D3523CAQ47745089-09D1B62F-BBD2-4EF9-A3E2-4BBC02BD3857Q50550677-BBFAABD3-943E-40D7-83C9-D8CA4353154AQ50568380-6B17C40D-7F93-4CF5-B7F2-A7EB8405ED11Q50574844-80BA601B-6A48-4020-B015-CA5C9A3BC8D3Q51662874-09D3FC28-E131-4308-B1AF-8CB93AA32834
P2860
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@ast
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@en
type
label
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@ast
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@en
prefLabel
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@ast
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@en
P1476
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.
@en
P2093
P356
10.1016/S0168-8278(99)80372-9
P478
31 Suppl 1
P577
1999-01-01T00:00:00Z